Tweet
Bidness ETC |
BlueBird Soars After Trial Results for Blood Disease Bloomberg Shares of Bluebird Bio Inc. (BLUE) soared to an all-time high after the company said its experimental gene therapy helped four patients with an inherited blood disorder go without regular blood transfusions. The four subjects had beta thalassemia major, ... Bluebird bio soars after release of study resultsBusinessweek Bluebird Bio Inc. (BLUE) Has Surged To A New High After LentiGlobin StudyRTT News Bluebird gene therapy shows promise for lethal blood diseaseMarketWatch Bidness ETC -Benzinga all 21 news articles » |
More...